Bruno Wohlschlegel
Chief Executive Officer at APONTIS PHARMA AG
Bruno Wohlschlegel active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APONTIS PHARMA AG | Chief Executive Officer | - | - |
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Chief Executive Officer | 31/08/2023 | - |
Career history of Bruno Wohlschlegel
Statistics
International
| Germany | 3 |
Operational
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Private companies | 1 |
|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
- Stock Market
- Insiders
- Bruno Wohlschlegel
- Experience
